Credit Suisse’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-42,562
| Closed | -$311K | – | 3056 |
|
|
2023
Q3 | $311K | Sell |
42,562
-2,589
| -6% | -$21.5K | ﹤0.01% | 2923 |
|
|
2023
Q2 | $471K | Sell |
45,151
-2,167
| -5% | -$20.9K | ﹤0.01% | 2808 |
|
|
2023
Q1 | $489K | Buy |
47,318
+1,995
| +4% | +$25.5K | ﹤0.01% | 2761 |
|
|
2022
Q4 | $624K | Buy |
45,323
+10,104
| +29% | +$141K | ﹤0.01% | 2640 |
|
|
2022
Q3 | $721K | Buy |
35,219
+4,744
| +16% | +$104K | ﹤0.01% | 2566 |
|
|
2022
Q2 | $590K | Sell |
30,475
-2,355
| -7% | -$48.2K | ﹤0.01% | 2736 |
|
|
2022
Q1 | $706K | Buy |
32,830
+1,408
| +4% | +$31.9K | ﹤0.01% | 2775 |
|
|
2021
Q4 | $867K | Buy |
31,422
+1,845
| +6% | +$50.9K | ﹤0.01% | 3423 |
|
|
2021
Q3 | $767K | Sell |
29,577
-4,189
| -12% | -$112K | ﹤0.01% | 3530 |
|
|
2021
Q2 | $917K | Sell |
33,766
-22,080
| -40% | -$539K | ﹤0.01% | 3455 |
|
|
2021
Q1 | $1.31M | Sell |
55,846
-15,333
| -22% | -$310K | ﹤0.01% | 3131 |
|
|
2020
Q4 | $1.09M | Buy |
71,179
+18,209
| +34% | +$231K | ﹤0.01% | 3276 |
|
|
2020
Q3 | $639K | Buy |
52,970
+5,689
| +12% | +$54K | ﹤0.01% | 3242 |
|
|
2020
Q2 | $481K | Buy |
47,281
+9,015
| +24% | +$92.9K | ﹤0.01% | 3352 |
|
|
2020
Q1 | $400K | Sell |
38,266
-5,668
| -13% | -$71.2K | ﹤0.01% | 3247 |
|
|
2019
Q4 | $704K | Buy |
43,934
+6,715
| +18% | +$103K | ﹤0.01% | 3360 |
|
|
2019
Q3 | $686K | Buy |
37,219
+1,455
| +4% | +$28.5K | ﹤0.01% | 3242 |
|
|
2019
Q2 | $705K | Sell |
35,764
-694
| -2% | -$14.1K | ﹤0.01% | 3181 |
|
|
2019
Q1 | $833K | Sell |
36,458
-18,558
| -34% | -$403K | ﹤0.01% | 3027 |
|
|
2018
Q4 | $1.11M | Buy |
55,016
+5,655
| +11% | +$117K | ﹤0.01% | 2694 |
|
|
2018
Q3 | $1.07M | Sell |
49,361
-12,705
| -20% | -$282K | ﹤0.01% | 2817 |
|
|
2018
Q2 | $1.38M | Sell |
62,066
-43,032
| -41% | -$880K | ﹤0.01% | 2770 |
|
|
2018
Q1 | $1.81M | Buy |
105,098
+24,780
| +31% | +$413K | ﹤0.01% | 2507 |
|
|
2017
Q4 | $1.33M | Buy |
80,318
+2,632
| +3% | +$44.9K | ﹤0.01% | 2772 |
|
|
2017
Q3 | $1.33M | Buy |
77,686
+36,402
| +88% | +$612K | ﹤0.01% | 2890 |
|
|
2017
Q2 | $668K | Sell |
41,284
-21,480
| -34% | -$340K | ﹤0.01% | 2950 |
|
|
2017
Q1 | $1.09M | Sell |
62,764
-16,056
| -20% | -$268K | ﹤0.01% | 2800 |
|
|
2016
Q4 | $1.33M | Buy |
78,820
+16,358
| +26% | +$273K | ﹤0.01% | 2796 |
|
|
2016
Q3 | $1.09M | Buy |
62,462
+6,015
| +11% | +$97.6K | ﹤0.01% | 2877 |
|
|
2016
Q2 | $811K | Buy |
56,447
+18,290
| +48% | +$229K | ﹤0.01% | 3092 |
|
|
2016
Q1 | $469K | Sell |
38,157
-6,574
| -15% | -$72.6K | ﹤0.01% | 3277 |
|
|
2015
Q4 | $543K | Sell |
44,731
-2,684
| -6% | -$33.1K | ﹤0.01% | 3319 |
|
|
2015
Q3 | $626K | Sell |
47,415
-30,543
| -39% | -$461K | ﹤0.01% | 3230 |
|
|
2015
Q2 | $1.28M | Buy |
77,958
+18,527
| +31% | +$308K | ﹤0.01% | 2948 |
|
|
2015
Q1 | $1.06M | Buy |
59,431
+6,353
| +12% | +$118K | ﹤0.01% | 2922 |
|
|
2014
Q4 | $1.01M | Buy |
53,078
+6,928
| +15% | +$117K | ﹤0.01% | 3131 |
|
|
2014
Q3 | $633K | Sell |
46,150
-7,162
| -13% | -$102K | ﹤0.01% | 3451 |
|
|
2014
Q2 | $870K | Sell |
53,312
-13,988
| -21% | -$202K | ﹤0.01% | 3415 |
|
|
2014
Q1 | $1.06M | Buy |
67,300
+9,544
| +17% | +$156K | ﹤0.01% | 3070 |
|
|
2013
Q4 | $992K | Buy |
57,756
+16,186
| +39% | +$249K | ﹤0.01% | 3288 |
|
|
2013
Q3 | $549K | Buy |
41,570
+15,247
| +58% | +$180K | ﹤0.01% | 3444 |
|
|
2013
Q2 | $297K | Buy |
+26,323
| New | +$280K | ﹤0.01% | 3634 |
|
Other funds holding ANGO
SFM
Credit Suisse's ANGO Position: Q4 2023 in Review
Credit Suisse sold out of AngioDynamics (ANGO) in Q4 2023, closing a stake of 42,562 shares — an estimated $311K sold.
Credit Suisse first reported a position in ANGO in Q2 2013 and held it in 42 quarters. The position peaked at $1.81M in Q1 2018. 150 funds tracked by Wall St. Rank hold ANGO as of Q4 2023.
- Credit Suisse reported no remaining AngioDynamics position as of Q4 2023 after selling out during the quarter.
- Credit Suisse sold 42,562 AngioDynamics shares in Q4 2023, an estimated $311K.
- Credit Suisse first reported a position in AngioDynamics in Q2 2013 and held it in 42 quarters.
- Credit Suisse's AngioDynamics position peaked at $1.81M in Q1 2018.
- 150 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2023.
Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.